Toluene diisocyanate: an assessment of carcinogenic risk following oral and inhalation exposure.
Although respiratory sensitization and pulmonary irritation have been the subject of particular studies with toluene diisocyanate (TDI), in recent years the potential carcinogenicity of TDI has been a reason for concern and speculation. This has arisen from the expectation that following exposure to TDI the chemical would hydrolyze at aqueous tissue surfaces to give rise to toluene diamine (TDA), a mutagen and rodent carcinogen. The chemistry of TDI suggests that the reaction with biological NH2 groups such as those on proteins, and polymerization to oligoureas, will compete with the hydrolysis reaction. This has been shown with results of in vitro studies where conjugation to protein occurs without detectable formation of TDA when protein solutions in saline are exposed to TDI vapor. Lower pH levels leading to high protonation of biological NH2 groups facilitate hydrolysis of TDI to TDA and subsequent formation of polyureas. These observations are consistent with comparative toxicokinetic studies in rats, which demonstrate significant levels of TDA following oral dosing with TDI--due to the acidic environment in the stomach--but not after inhalation. These results provide an explanation for the tumors observed in rodents after oral dosing of TDI in corn oil, but not after inhalation. Inhalation is the relevant route of human exposure for TDI and the toxicokinetics of TDI exposure at occupational exposure limits have been studied. These data provide a means by which quantitative estimates of the risk of carcinogenicity possibly resulting from the intermediate formation of TDA during TDI exposure can be obtained. Several calculations have been made, all of which lead to the conclusion that TDI exposure by inhalation at the recommended occupational limits will not give rise to significant carcinogenic risk.
Doe
J E
JE
Zeneca Central Toxicology Laboratory Cheshire, England.
Hoffmann
H D
HD
D000280:Administration, Inhalation; D000284:Administration, Oral; D000818:Animals; D015197:Carcinogenicity Tests; D006801:Humans; D009152:Mutagenicity Tests; D009369:Neoplasms / Q000453:epidemiology; D016273:Occupational Exposure; D010655:Phenylenediamines / Q000633:toxicity; D012098:Reproduction / Q000187:drug effects; D018570:Risk Assessment; D014051:Toluene 2,4-Diisocyanate / Q000737:chemistry / Q000493:pharmacokinetics* / Q000633:toxicity*
D010655:Phenylenediamines; D014051:Toluene 2,4-Diisocyanate